Ricard Solá Lamoglia-rekin lankidetzan egindako argitalpenak (10)

2015

  1. Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

    Genes and Immunity, Vol. 16, Núm. 5, pp. 297-300

2014

  1. Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 1, pp. 1-8

2009

  1. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

    Hepatology, Vol. 50, Núm. 6, pp. 1702-1708

2008

  1. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C

    Journal of Hepatology, Vol. 48, Núm. 5, pp. 721-727

  2. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain

    Journal of Hepatology, Vol. 48, Núm. 1, pp. 20-27

  3. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C

    Hepatology, Vol. 47, Núm. 3, pp. 810-816

2007

  1. Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: A randomized trial

    Journal of Viral Hepatitis, Vol. 14, Núm. 2, pp. 89-95

  2. Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: Early prediction of sustained virological response rate

    Alimentary Pharmacology and Therapeutics, Vol. 25, Núm. 8, pp. 899-906

2003

  1. Comparative study of the efficacy of an induction dose of interferon-α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C

    Journal of Viral Hepatitis, Vol. 10, Núm. 6, pp. 437-445

1995

  1. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study

    Hepatology, Vol. 21, Núm. 3, pp. 674-679